Transaction #1830 · Form 4 · 0001193125-25-245114
ATOSSA THERAPEUTICS, INC. · Stock award · Stock Option (right to buy)
ATOSSA THERAPEUTICS, INC. · Transacted October 14, 2025 · Filed October 21, 2025
What does this filing report?
An SEC Form 4 filing for ATOSSA THERAPEUTICS, INC. records a stock award involving Stock Option (right to buy) on October 14, 2025. The reported quantity was 578,000. The filing date is October 21, 2025. This is one transaction record; amounts are not allocated among any joint reporting owners.
The acquisition category describes how securities were received. It does not by itself establish a cash purchase of common stock. Read the transaction code definitionsand the original filing before interpreting the amounts.
Transaction details
- Company
- ATOSSA THERAPEUTICS, INC.
- Company CIK
- 0001488039
- Security type
- Derivative
- Acquisition type
- Stock award · Code A
- Quantity acquired
- 578,000
- Reported price
- 0
- Reference value
- 0
- Currency
- Currency not specified
- Ownership
- Direct
- Holdings after transaction
- 578,000
- Ownership description
- Not reported
- SEC acceptance time
- Oct 21, 2025, 4:10 PM EDT
- 10b5-1 indication
- Not indicated
Reference value is reported quantity × reported price. It is not a confirmed cash payment or an estimate of a derivative's economic value. A missing currency is not assumed to be USD.
Reporting owners
- Daniel Mark James ↗
Chief Financial Officer
CIK 0002092593
These are the reporting owners named in the filing. Quantities and amounts are not allocated among co-reporters. Roles reflect this filing, not a current profile.
Company listings
This transaction is not mapped to a specific company listing.
Derivative terms
- Underlying security
- Common Stock
- Underlying quantity
- 578,000
- Conversion / exercise price
- 1.03
- Exercise date
- Not reported
- Expiration date
- October 14, 2035
Filing footnotes & remarks
- F1
- The options shall vest with respect to 25% on October 14, 2026, with the remaining 75% to vest in equal quarterly installments over the follwing three years, subject to the Reporting Person's continued service to the Issuer through each applicable vesting date.
Footnotes are reproduced as plain text from the current source filing. For the full context, read the original SEC filing.
This record was updated Eastern Time. This is the stored record update time, not the transaction date. Report a correction.